How to manage anticoagulation in patients undergoing invasive procedures

2016-07-13

James Douketis

This lecture was recorded at the 2nd McMaster International Review Course in Internal Medicine in Kraków, Poland. To learn more, visit www.mircim.eu.

See also

Upper extremity thrombosis and risk for DVT of lower extremities Paget-Schroetter syndrome and subclavian vein thrombosis are very rarely discussed. Could you comment on these diseases and the risk of pulmonary embolism? Is this a risk for deep venous thrombosis of the lower extremity?
Common genetic thrombophilias and hormonal contraception Is it advisable to screen patients for the most common genetic thrombophilias before starting hormonal contraception?
Updates in ACCP antithrombotic guidelines What is new in the updated American College of Chest Physicians antithrombotic guidelines? What are the most important changes?
Update on the management of deep vein thrombosis and pulmonary embolism A lecture by Prof. Jeffrey Weitz, from McMaster University, Canada, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2016.
Management tips for use of the new oral anticoagulants Prof. James Douketis, from McMaster University, Canada, addresses real-world "what if" scenarios for managing patients on NOACs, such as how to choose the right NOAC, determine if a patient needs a procedure or surgery, understand safety of concomitant drugs, and prescribe off-label use of NOACs.

How to manage anticoagulation in patients undergoing invasive procedures

Social Media